CIAM
CGON icon

Caitong International Asset Management’s CG Oncology CGON Stock Holding History

Caitong International Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,693
Closed -$318K – 3048
2026
Q1 		$318K Buy
+4,693
New +$266K 0.06% 275
2025
Q3 		– Sell
-126
Closed -$3.28K – 2018
2025
Q2 		$3.28K Sell
126
-568
-82% -$13.7K ﹤0.01% 1200
2025
Q1 		$17K Buy
694
+355
+105% +$9.99K 0.01% 779
2024
Q4 		$9.72K Buy
+339
New +$11.6K 0.01% 958

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caitong International Asset Management's CGON Position: Q2 2026 in Review

Caitong International Asset Management sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 4,693 shares — an estimated $318K sold.

Caitong International Asset Management first reported a position in CGON in Q4 2024 and held it in 4 quarters. The position peaked at $318K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Caitong International Asset Management reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 4,693 CG Oncology shares in Q2 2026, an estimated $318K.
  • Caitong International Asset Management first reported a position in CG Oncology in Q4 2024 and held it in 4 quarters.
  • Caitong International Asset Management's CG Oncology position peaked at $318K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.